Which patients are good candidates for synthetic mid-urethral slings? Howard B. Goldman Invited Commentary Pages: 327 - 329
Darifenacin is an effective and well-tolerated once-daily treatment for overactive bladder Rodney A. Appell Clinical Trials Report Pages: 333 - 333
A review of quality-of-life questionnaires for urinary incontinence and overactive bladder: Which ones to use and why? Louis S. MatzaTeresa M. ZyczynskiTamara Bavendam OriginalPaper Pages: 336 - 342
Urodynamics in the era of tension-free slings: Defining the role J. Christian Winters OriginalPaper Pages: 343 - 347
Detrusor after-contraction: Is this important? Francesco PesceEmanuele Rubilotta OriginalPaper Pages: 353 - 358
Preview of new drugs for overactive bladder and incontinence: Darifenacin, solifenacin, trospium, and duloxetine Richard T. KershenMike Hsieh OriginalPaper Pages: 359 - 367
Randomized surgical trials for the treatment of stress urinary incontinence Gary E. Lemack Clinical Trials Report Pages: 371 - 371
Comparison between a modified burch procedure and a suburethral sling Gary E. Lemack Clinical Trials Report Pages: 371 - 372
Porcine dermal sling versus tension-free vaginal tape Gary E. Lemack Clinical Trials Report Pages: 372 - 373
Synthetic sling options for stress urinary incontinence Raviender BukkapatnamLarissa V. Rodríguez OriginalPaper Pages: 374 - 380
Urologic applications of botulinum toxin therapy for voiding dysfunction Raymond RackleyJoseph Abdelmalak OriginalPaper Pages: 381 - 388
The use of graft materials in anterior compartment pelvic reconstruction J. Sean BegleyKathleen C. Kobashi OriginalPaper Pages: 397 - 402
Female sexual dysfunction following vaginal surgery: Myth or reality? Hari S. G. R. TunuguntlaAngelo E. Gousse OriginalPaper Pages: 403 - 411
